News Column

Johnson & Johnson Reports Q3 Earnings Down

Oct. 16, 2012
johnson & johnson

U.S. pharmaceutical concern Johnson & Johnson on Tuesday reported a fall in third quarter net income to $3 billion, or $1.15 a share, down from $3.2 billion in the same period last year.

The 7.3 percent decline was attributed to increased research and production costs.

Revenues rose to $17.1 billion, a rise of 6.5 percent over the same quarter last year. The stronger dollar hurt the value of foreign sales, which otherwise would have grown 10.8 percent over the same quarter last year, the company said.



Source: Copyright 2012 dpa Deutsche Presse-Agentur GmbH